Alanna Morris, MD, MSc, joins Craig Beavers, PharmD, to discuss the 2026 ACC HFpEF pathway, foundational therapy, and where pharmacists fit in.
Alanna Morris, MD, MSc
Advertisement
Articles by Alanna Morris, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
3
Semaglutide 2 mg Tied to Lower MACE Risk Than Tirzepatide Switch
4
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
5